Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)

NCT03048617 is registered in ClinicalTrials.gov with Stealth BioTherapeutics Inc. as lead sponsor.

NCT NCT03048617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03048617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)
Lead sponsor
Stealth BioTherapeutics Inc.
Phase
Observational
Overall status
Completed
Start date
February 13, 2017
Completion date
March 7, 2019
Enrollment
215 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

primary mitochondrial disease